U.S. Markets closed
  • Gold

    1,768.40
    -9.80 (-0.55%)
     
  • Silver

    23.03
    +0.46 (+2.05%)
     
  • EUR/USD

    1.1696
    -0.0034 (-0.2924%)
     
  • 10-Yr Bond

    1.3360
    +0.0120 (+0.91%)
     
  • Vix

    20.87
    -3.49 (-14.33%)
     
  • GBP/USD

    1.3619
    -0.0045 (-0.3282%)
     
  • USD/JPY

    109.7800
    +0.5600 (+0.5127%)
     
  • BTC-USD

    42,442.89
    -1,738.58 (-3.94%)
     
  • CMC Crypto 200

    1,089.55
    +49.07 (+4.72%)
     
  • FTSE 100

    7,083.37
    +102.39 (+1.47%)
     
  • Nikkei 225

    29,639.40
    -200.31 (-0.67%)
     

Why I'm Not Worried About Teladoc's Q2 Earnings Miss

·5 min read
Why I'm Not Worried About Teladoc's Q2 Earnings Miss
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

As a Teladoc Health (NYSE: TDOC) shareholder, I cringed when I saw the stock's initial sell-off on July 28, the day the company released its second-quarter results last week -- it fell as much as 11.8% before recovering. Although the company's net loss of $0.86 per share was worse than the $0.56 loss analysts were expecting, it was actually a pretty good quarter for the company, and there were many positives to pull from it.